Diabetologia

, Volume 57, Issue 10, pp 2232–2234 | Cite as

An explanation for recent discrepancies in levels of human circulating betatrophin

Letter

Keywords

ANGPTL8 Betatrophin C19orf80 Lipasin RIFL 

Abbreviations

ANGPTL

Angiopoietin-like protein

LPL

Lipoprotein lipase

References

  1. 1.
    Zhang R (2012) Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun 424:786–792PubMedCrossRefGoogle Scholar
  2. 2.
    Ren G, Kim JY, Smas CM (2012) Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. Am J Physiol Endocrinol Metab 303:E334–E351PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Quagliarini F, Wang Y, Kozlitina J et al (2012) Atypical angiopoietin-like protein that regulates ANGPTL3. Proc Natl Acad Sci U S A 109:19751–19756PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Wang Y, Quagliarini F, Gusarova V et al (2013) Mice lacking ANGPTL8 (betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proc Natl Acad Sci U S A 110:16109–16114PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Yi P, Park JS, Melton DA (2013) Betatrophin: a hormone that controls pancreatic beta cell proliferation. Cell 153:747–758PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Espes D, Lau J, Carlsson PO (2014) Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes. Diabetologia 57:50–53PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Fenzl A, Itariu BK, Kosi L et al (2014) Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals. Diabetologia 57:1204–1208PubMedCrossRefGoogle Scholar
  8. 8.
    Espes D, Martinell M, Carlsson PO (2014) Increased circulating betatrophin concentrations in patients with type 2 diabetes. Int J Endocrinol 2014:323407PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Fu Z, Berhane F, Fite A, Seyoum B, Abou-Samra AB, Zhang R (2014) Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity. Sci Rep 4:5013PubMedGoogle Scholar
  10. 10.
    Chang JK, Lyu RM, Chen XQ et al (2013) Detection of C-terminal betatrophin peptides in human plasma and rodent liver. In: Nishiuchi Y, Teshima T (eds) The 4th Asia-Pacific International Peptide Symposium. Peptide Science, Japan, pp 243–246Google Scholar
  11. 11.
    Gómez-Ambrosi J, Pascual E, Catalán V et al (2014) Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes. J Clin Endocrinol Metab (in press)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Center for Molecular Medicine and Genetics, School of MedicineWayne State UniversityDetroitUSA
  2. 2.Department of MedicineHamad Medical CorporationDohaQatar

Personalised recommendations